StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 17/3038% above fair value
$698.47+8.23 (+1.19%)

Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –

IDEXX Laboratories market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

IDEXX Laboratories's market cap was $55.42B on Nov 11, 2026, against $60.23B a year earlier. Over the last 5 years it ranged from $27.18B to $60.23B, with a median of $41.45B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$55.42B+2.4%
2025Dec 31, 2025$54.12B+59.6%
2024Dec 31, 2024$33.92B-26.4%
2023Dec 29, 2023$46.11B+36.2%
2022Dec 30, 2022$33.86B-39.4%
2021Dec 31, 2021$55.89B+31.1%
2020Dec 31, 2020$42.64B+90.1%
2019Dec 31, 2019$22.43B+39.3%
2018Dec 31, 2018$16.10B+14.5%
2017Dec 29, 2017$14.07B+31.6%
2016Dec 30, 2016$10.69B+60.7%
2015Dec 31, 2015$6.65B-13.5%
2014Dec 31, 2014$7.68B+32.0%
2013Dec 31, 2013$5.82B+11.2%
2012Dec 31, 2012$5.24B+15.8%
2011Dec 30, 2011$4.52B+9.1%
2010Dec 31, 2010$4.14B+24.6%
2009Dec 31, 2009$3.33B–

More IDEXX Laboratories figures

See a number that looks wrong?